Recent Press Coverage Linking Azithromycin to Increased Risk of Sudden Death

Several media outlets have reported on a study that links azithromycin to sudden death. Azithromycin is a commonly used antibiotic, often prescribed to treat respiratory infections, ear infections, and sexually transmitted diseases (STDs).

As the public health agency tasked with researching and developing STD treatment guidelines, we want to take this opportunity to point out that the findings from this study may not necessarily apply to patients who are treated with azithromycin for chlamydia or gonorrhea. It is important to note that a five day regimen of azithromycin was studied and discussed in recent media reports -- not a single dose regimen as recommended for chlamydia or dual therapy for gonorrhea. For additional information about Azithromycin from the U.S. Food and Drug Administration, please visit http://www.fda.gov/Drugs/DrugSafety/ucm341822.htm

Do not modify treatment regimens for patients receiving azithromycin for chlamydia and gonorrhea. CDC’s guidance for treating chlamydia and gonorrhea with azithromycin remain as follows:

Recommended Regimens for Treating Chlamydial Infections

Recommended Regimens for Treating Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum

The Sexually Transmitted Diseases Treatment Guidelines, 2010 can be found in its entirety at /std/treatment/2010/.

If you have questions or concerns, please contact 1-800-CDC-INFO.